Your browser doesn't support javascript.
loading
An Affinity Capture Elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug.
Bourdage, James S; Cook, Carolyn A; Farrington, Daphne L; Chain, Jana S; Konrad, Robert J.
Afiliación
  • Bourdage JS; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, United States. bourdageja@lilly.com
J Immunol Methods ; 327(1-2): 10-7, 2007 Oct 31.
Article en En | MEDLINE | ID: mdl-17716682
ABSTRACT
Monoclonal antibody therapeutics typically have relatively long half-lives and can be dosed at high levels. Although formation of anti-drug antibodies (ADA) is relatively rare, detection of these antibodies can be very difficult in the presence of high circulating levels of drug. Typically these ADA are detected by bridging ELISAs which can be very sensitive to even low levels of drug. We describe an ELISA method based on affinity capture of ADA on solid-phase drug followed by removal of excess free drug, release and transfer of bound ADA and subsequent detection using biotinylated drug. The assay is both sensitive and highly tolerant to free drug with detection of 500 ng/ml of ADA readily achieved in the presence of 500 mug/ml of drug.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoensayo / Anticuerpos / Anticuerpos Monoclonales Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: J Immunol Methods Año: 2007 Tipo del documento: Article País de afiliación: Estados Unidos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoensayo / Anticuerpos / Anticuerpos Monoclonales Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: J Immunol Methods Año: 2007 Tipo del documento: Article País de afiliación: Estados Unidos